Navigation Links
How Early Can We Detect Cardiovascular Disease Less Expensively ... Even in Childhood?

'PAT' is the Invisible Signal

Itamar Medical

American Heart Association's Scientific Sessions 2007

Press Breakfast

ORLANDO, Fla., Nov. 4 /PRNewswire/ --

WHO: Dr. Amir Lerman, Professor of Medicine, Mayo Clinic, Rochester, MN

Dr. Peter Friberg, Sahlgrenska University Hospital, Goeteborg,


Mr. Israel Schreiber, President and CEO, Itamar Medical

Dr. Mark Pritzker, Cardiologist, University of Minnesota Medical


Dr. Giora Yaron -- Co-Chairman, Itamar Board of Directors.

WHAT: Itamar Medical AHA Press Breakfast --

Endothelial dysfunction -- the underappreciated cardiovascular

risk factor

WHEN: Monday, November 5, 2007 8:00 a.m.

WHERE: The Aviary Room

Celebration Hotel

700 Bloom St.

Celebration, FL.

WHY: Find out why PAT Technology is the "buzz" at AHA

It's been nearly a decade since the Nobel Prize was awarded for

discovering the link between endothelial dysfunction and

cardiovascular disease. The key is recognizing subtle changes in

blood flow, called peripheral arterial tone (PAT). Research

released at this AHA conference validates this basic science.

-- Framingham Heart Study uses PAT Technology to find links

between endothelial dysfunction and cardiovascular risk factors

-- Swedish scientists note that anger, depression and anxiety in

children are connected to measurable endothelial changes that

precedes heart disease

-- An international team of scientists discovers that endothelial

damage is widespread in malaria, suggesting new avenues for


-- Endothelial damage is common in insulin resistant patients;

treating insulin resistance could change the outcome for many

-- Certain pacemakers implanted to boost the right side of the

heart are linked to endothelial damage and decreased heart


About Itamar Medical

Itamar Medical Ltd., established in 1997, is a public (TASE: ITMR) medical technology company that developed the proprietary PAT(TM) (Peripheral Arterial Tone) signal. The PAT signal is a non-invasive "window" to the cardiovascular system and the autonomic nervous system.

PLEASE RSVP to: Yvette Watson;

(202) 944-1969.

SOURCE Itamar Medical Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Gene linked to early puberty in girls
2. Cancer drugs in development nearly doubled since 1995
3. Nearly all asthma deaths preventable
4. Ductal lavage may detect early breast cancer
5. Doctors advice early anemia tests
6. Heart disease threat starts early in life for Diabetics
7. Early detection of prostate cancer
8. Early detection of heart attack
9. Early puberty linked to nutrition
10. Exercise to Prevent Early Breast Cancer
11. Drug Found To Bring Relief For Individuals With Early Parkinson’
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... authorized OSHA Training Institute Education Center headquartered in Northern California, has issued an ... extreme heat at their worksites. Employers with workers exposed to high temperatures ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/27/2016)... California (PRWEB) , ... June ... ... pioneer in the patient payment industry today announced its strategic partnership with ... health system workflows. , The two companies’ proven, proprietary technology combine to ...
(Date:6/27/2016)... ... June 27, 2016 , ... A ... revolutionize the emergency ambulance transport experience for the millions of people who require ... has disrupted the taxi industry through the use of technology. Now, SmartEMS has ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
Breaking Medicine Technology: